PT - JOURNAL ARTICLE AU - Ughi, Nicola AU - Adinolfi, Antonella AU - Chevallard, Michel AU - Belloli, Laura AU - Senatore, Michele AU - Toscano, Alessandro AU - Bellone, Andrea AU - Giannattasio, Cristina AU - Tarsia, Paolo AU - Puoti, Massimo AU - Scaglione, Francesco AU - Colombo, Fabrizio AU - Bertuzzi, Michaela AU - Bettoni, Giuseppe AU - Ferrazzi, Davide AU - Maloberti, Alessandro AU - Dicuonzo, Armanda AU - Del Gaudio, Francesca AU - Rossetti, Claudio AU - Epis, Oscar Massimiliano AU - , TI - Development and external validation of a diagnostic multivariable prediction model for a prompt identification of cases at high risk for SARS-COV-2 infection among patients admitted to the emergency department AID - 10.1101/2021.05.26.21257834 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.26.21257834 4099 - http://medrxiv.org/content/early/2021/05/29/2021.05.26.21257834.short 4100 - http://medrxiv.org/content/early/2021/05/29/2021.05.26.21257834.full AB - Background An urgent need exists for an early detection of cases with a high-risk of SARS-CoV-2 infection, particularly in high-flow and -risk settings, such as emergency departments (EDs). The aim of this work is to develop and validate a predictive model for the evaluation of SARS-CoV-2 infection risk, with the rationale of using this tool to manage ED patients.Methods A retrospective study was performed by cross-sectionally reviewing the electronical case records of patients admitted to Niguarda Hospital or referred to its ED in the period 15 March to 24 April 2020.Derivation sample was composed of non-random inpatients hospitalized on 24 April and admitted before 22 April 2020. Validation sample was composed of consecutive patients who visited the ED between 15 and 25 March 2020. The association between the dichotomic outcome and each predictor was explored by univariate analysis with logistic regression models.Results A total of 113 patients in the derivation sample and 419 in the validation sample were analyzed. History of fever, elder age and low oxygen saturation showed to be significant predictors of SARS-CoV-2 infection. The neutrophil count improves the discriminative ability of the model, even if its calibration and usefulness in terms of diagnosis is unclear.Conclusion The discriminatory ability of the identified models makes the overall performance suboptimal; their implementation to calculate the individual risk of infection should not be used without additional investigations. However, they could be useful to evaluate the spatial allocation of patients while awaiting the result of the nasopharyngeal swab.What is already known on this topic 1 year after the onset of the coronavirus disease 2019 (COVID-19) pandemic, the trend of its spread has not shown a substantial global reduction. An urgent need exists for efficient early detection of cases with a high risk of SARS-CoV-2 infection and a number of diagnostic prediction models have been developed, but a few models were externally validated in high-flow and –risk settings, such as emergency departments (EDs).What this study adds This study develops and validate predictive models for the evaluation of SARS-CoV-2 infection risk, with the rationale of using these tools to promptly manage patients who are afferent to the ED, allocating them accordingly to the risk of infection while awaiting swab result. History of fever, older age and low oxygen saturation showed to be significant predictors of the presence of SARS-CoV-2 infection. The use of laboratory findings, such as neutrophil count, showed to improve the discriminative ability of the model, even if its calibration and usefulness in terms of diagnosis is unclear.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere was no explicit funding for the development of this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted within the protocol approved the ethics committee Milano Area 3 (register number 249-13052020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be made available upon reasonable request.